Postoperative radiotherapy for non-small cell lung cancer
作者:Sarah Burdett, Larysa H. M. Rydzewska, Jayne F. Tierney, David J. Fisher, Mahesh Parmar, Rodrigo Arriagada, Jean‐Pierre Pignon, Cecile Le Pechoux, on behalf of the PORT Meta-analysis Trialists Group · 发表于:Cochrane Database of Systematic Reviews · 年份:2016 · DOI:10.1002/14651858.cd002142.pub4 · 被引用次数:198 · 研究领域:Lung Cancer Diagnosis and Treatment、Radiomics and Machine Learning in Medical Imaging、Lung Cancer Research Studies
BACKGROUND: The role of postoperative radiotherapy (PORT) in the treatment of patients with completely resected non-small cell lung cancer (NSCLC) was not clear. A systematic review and individual participant data meta-analysis was undertaken to evaluate available evidence from randomised controlled trials (RCTs). These results were first published in Lung Cancer in 2013. OBJECTIVES: To evaluate the effects of PORT on survival and recurrence in patients with completely resected NSCLC. To investigate whether predefined patient subgroups benefit more or less from PORT. SEARCH METHODS: We supplemented MEDLINE and CANCERLIT searches (1965 to 8 July 2016) with information from trial registers, handsearching of relevant meeting proceedings and discussion with trialists and organisations. SELECTION CRITERIA: We included trials of surgery versus surgery plus radiotherapy, provided they randomised participants with NSCLC using a method that precluded prior knowledge of treatment assignment. DATA COLLECTION AND ANALYSIS: We carried out a quantitative meta-analysis using updated information from individual participants from all randomised trials. We sought data on all participants from those responsible for the trial. We obtained updated individual participant data (IPD) on survival and date of last follow-up, as well as details on treatment allocation, date of randomisation, age, sex, histological cell type, stage, nodal status and performance status. To avoid potential bias, we reques...